For research use only. Not for therapeutic Use.
Anticancer agent 7 (Example 5) is an anti-cancer agent with an IC50 of 5 μM for H1650 lung cancer cells[1].
Anticancer agent 7 exhibits anti-proliferative effects. Anticancer agent 7 is useful in the treatment of a variety of disorders, including as a therapy in cancer treatment[1].
| Catalog Number | I044736 |
| CAS Number | 2088956-21-0 |
| Synonyms | N-[(3R,4R,5S)-5-(3,6-dichlorocarbazol-9-yl)-4-hydroxyoxan-3-yl]-4-(trifluoromethoxy)benzenesulfonamide |
| Molecular Formula | C24H19Cl2F3N2O5S |
| Purity | ≥95% |
| InChI | InChI=1S/C24H19Cl2F3N2O5S/c25-13-1-7-20-17(9-13)18-10-14(26)2-8-21(18)31(20)22-12-35-11-19(23(22)32)30-37(33,34)16-5-3-15(4-6-16)36-24(27,28)29/h1-10,19,22-23,30,32H,11-12H2/t19-,22+,23+/m1/s1 |
| InChIKey | XXCAYCBBVUGGDY-OIBXWCBGSA-N |
| SMILES | C1C(C(C(CO1)N2C3=C(C=C(C=C3)Cl)C4=C2C=CC(=C4)Cl)O)NS(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F |
| Reference | [1]. Michael Ohlmeyer, et al. Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents. WO2017044569A1. |
